Table 1a.
Baseline characteristics of enrolled workers by occupational classes, men. The RoCAV Study
| Men (No.=925) | Manager/ director | Non-manual | Skilled manual | Unskilled manual | p-value* |
| No., % | 153, 16.5% | 382, 41.3% | 245, 26.5% | 145, 15.7% | - |
| Age (years) | 64.2±7.3 | 63.5±7.0 | 63.8±6.9 | 63.3±7.2 | 0.67 |
| Current-smokers | 13% | 17% | 18% | 25% | 0.04 |
| Ever-smokers | 51% | 52% | 52% | 66% | 0.02 |
| Total cholesterol (mg/dL) | 207.0±3.1 | 204.4±2.0 | 208.2±2.4 | 205.0±3.2 | 0.63 |
| HDL cholesterol (mg/dL) | 53.8±1.1 | 54.2±0.7 | 54.4±0.9 | 53.3±1.1 | 0.89 |
| Blood glucose (mg/dL) | 102.3±2.1 | 101.3±1.4 | 100.3±1.7 | 103.7±2.2 | 0.65 |
| Systolic blood pressure (mmHg) | 136.2±1.3 | 137.4±0.9 | 137.0±1.6 | 138.1±1.4 | 0.79 |
| Body Mass Index (kg/m2) | 26.7±0.3 | 26.9±0.2 | 27.3±0.2 | 27.0±0.3 | 0.51 |
| Positive history of Diabetes | 15% | 12% | 12% | 19% | 0.11 |
| Positive history of Atrial Fibrillation | 4% | 3% | 2% | 4% | 0.70 |
| Current treatment for | |||||
| Hypertension | 37% | 44% | 40% | 45% | 0.41 |
| Hypercholesterolemia | 20% | 21% | 21% | 28% | 0.33 |
| Antiplatelet treatment | 17% | 15% | 16% | 18% | 0.90 |
| Anticoagulant treatment | 3% | 3% | 2% | 4% | 0.73 |
| SCORE 10-year CVD risk (%) | 5.6 | 5.4 | 5.5 | 6.0 | 0.16 |
| CUORE 10-year CHD risk (%) | 14.1 | 14.0 | 14.4 | 16.0 | 0.06 |